Fingerprint
Dive into the research topics of 'High p95HER2/HER2 ratio associated with poor outcome in trastuzumab-treated HER2-positive metastatic breast cancer ncctg N0337 and NCCTG 98-32-52 (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically